Breast cancer (BC) is diagnosed commonly in younger Ghanaian women compared to women in western countries.
What are the implications for research, policy, or practice?
Features of worse prognosis are found to be associated with younger age ta diagnosis with breast cancer.
Background
Breast cancer (BC) is the leading cause of cancer related morbidity and mortality in Ghana, in keeping with global statistics. [1] [2] [3] Publications from 1956 to 2015 on breast cancer (BC) in Ghana found the disease to be relatively common in younger Ghanaian women, who usually present late with advanced stages of the disease with poor treatment outcomes. 4, 5 The aim of this institution-based retrospective study was to compare the clinico-pathological features of BC in young women (≤39 years old) with older women (≥40 years old).
Method Study Site
Data were gathered from the Department of Pathology, School of Biomedical Sciences, University of Ghana Medical School. This is the largest Pathology Department in the country. It reports between 5,000 and 8,000 histology cases annually. This Department receives surgical specimens from Korle-Bu Teaching Hospital, (the largest referral hospital in Ghana) and other hospitals in Ghana.
Study design
This was a retrospective study covering the period 2001-2014.
Data collection and analysis
We retrospectively analysed data from 4,336 Ghanaian women with histologically confirmed breast cancers. The women were divided into two age groups: ≤39 years (group A) and ≥40 years (group B). There following data were reviewed: age at histological diagnosis, tumour size (cm), histological subtype, histological grade, lymph node status, TNM (Tumour, nodal involvement and distant metastasis) stage and positive margins; -defined as breast cancer cells found within 2.0mm of the resection margins. Data were entered into and analysed using SPSS software (version 23).
The clinico-pathological characteristics and prognostic factors were compared between the two age groups using paired samples test. Table 5 ).
Of the cases from which lymph nodes were retrieved from the axillary tail, a total of 179 (70. (Table 5 ).
Discussion
In this retrospective descriptive study, it was noted that a significant proportion (19.6 per cent) of the women diagnosed with BC were younger than 40 years of age. This value is far greater than the 5.0 per cent found in Native American women 6 and the 10.6 per cent in Brazilian women, 7 but compares favourably with values such as 14.9
per cent in African American women. 8 The current figure for this study is however lower than the 30-40 per cent found in other studies. 9, 10 Several studies globally have demonstrated that breast cancers in younger women have a more aggressive biology, correlating with poorer outcomes when compared with older women 11, 12 The implication for this age category of Ghanaian women in this study is that they may have worse prognosis. However, age alone will not explain the poor prognosis of breast cancer in these young Ghanaian women. Further studies on predisposition, gene and environmental interaction in this age group may increase our understanding of the situation.
The great majority (80.4 per cent) of the women diagnosed with BCs were aged 40 years and above. Breast cancer is a disease that is commoner in the elderly. 13 As the population ages, increasing proportion of women aged 40 years and above will be diagnosed with breast cancer. 13, 14 Ghanaian women are ageing and thus the proportion of the women 40 years and above is similarly increasing and hence the high percentage in this study. Our findings are in keeping with the global statistics 13, 14 and also with studies from Nigeria.
15,16
The common primary symptoms of BC in both groups of women were palpable lumps. This is to be expected, as there is neither a population-based breast cancer screening programme, nor a routine mammography screening programme as commonly pertains in the western societies. Most Ghanaian women are either screened voluntarily or will seek medical advice when an abnormality is found in the breast. Furthermore, Ghanaian women aged 39 years or younger are even less likely to participate in a voluntary screening programme, they are thus more likely to present with a self-discovered obvious abnormality. The presentation of BC in this study is similar to those reported by Kwong et al. 17 on BCs among Chinese women younger than 40 years. The current study also found that bilateral BCs were more common in younger women as compared to those aged 40 years and above. This finding differs from the study of Nelly et al in Egypt who found that bilateral BCs were frequent in older women. 18 Symptoms of advanced clinical stage of BC at presentation such as skin involvement, axillary lymphadenopathy, nipple discharge, breast pain, chest wall invasion and nipple retraction in this study were frequent in younger women compared to older women. Late and advanced clinical stage of BC presentation in younger women in this current study is in accord with previous studies in Ghana and across the globe.
19-22
Delayed presentation of women with breast cancer at health facilities has been found to be associated with poor prognosis. 23 Late presentation (after 3 months) of breast cancer in this study was common in both groups, but more so in the younger age group [(75.7 per cent vs. 70.1 per cent) p=0.000]. This differs from the study by Arndt et al. 24 in Germany that found that older women waited longer than younger women before presenting their symptoms to a physician.
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Mastectomy was commonly performed as a treatment option for BC in the older women compared to the younger women (p=0.002). The reasons for these differences are not apparent, but may be attributed to the choice of the BC patient, age at diagnosis, psychological and cosmetic impact on body image after surgery. These suggestions are supported by studies comparing mastectomy as a treatment option for breast cancer between women younger than 40 years and older women. 25, 26 Stratifying the size of the primary breast tumours in this current study, it was found that larger tumours, particularly those greater than 5.0cm were common in the younger age group compared to the older age group (p=0.002). These findings support results of other studies that found larger tumour to be commonly associated with young age at diagnosis of BC. 27, 28 This however differs from Elrasheid et al. 29 study in the Galway University Hospital, that found larger tumour size to be commoner in older women.
The current study found that younger women with BCs are more likely to have positive tumour margins after surgery (mastectomy and excisions) compared to the older women. This may be a reflection of the larger tumours found in the younger age group. However, the positive tumour margin rates found in both groups are within the range of values from 4.0 per cent to 44.1 per cent found in previous studies in Ghana and globally. 30, 31 Invasive ductal carcinoma (IDC-NOS) was the commonest BC in both groups. This is in line with studies in West Africa that found IDC-NOS as the commonest invasive BC in women. 32 DCIS, malignant phyllodes, neuroendocrine, lymphomas and sarcomas were commoner in the younger age group while invasive lobular, medullary, papillary, metaplastic and apocrine carcinomas were commoner in women aged 40 years and above. This in keeping with the findings of what Elrasheid et al. 29 Higher histological grade (grade 3) of breast cancer at diagnosis was common in younger women compared to the older women (p=0.002). This is in accordance with studies that found younger age at diagnosis of BC to be associated with higher histological grades of invasive BCs.
33,34
The current study found that more than 50.0 per cent of the study population had 4 or more nodal involvement by breast cancer. This may be a reflection of the large primary tumour sizes in both groups and thus support the findings of Carter et al. 35 who found larger tumour to be associated with increased risk of nodal involvement. Our findings however differ from those of Bonnier et al. 36 that concluded that younger women diagnosed with BC are more likely to have higher positive lymph nodes compared to older women.
Higher TNM stages of invasive BCs (Stages 3 and 4 combined) were common in women aged 39 years or younger compared to those aged 40 years or more (p=0.033). This differs from studies that found higher combined TNM stages to be common in older women compared to the younger age group. 18, 29, 37 Our current findings however support studies that found young women, particularly African American women, with ancestral origins from Africa presenting to health facilities with advanced stages of the disease. 38, 39 Part of the explanation given for young women having higher TNM stage at presentation has been suggested to be the increased potential for a delayed diagnosis.
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Conclusion
This is the first study that compared the clinicopathological characteristics of breast cancer in Ghanaian women younger than 40 years of age and their older counterparts. The study found that about one-fifth of the study population were women younger than 40 years of age. This group of women presented late with signs and symptoms of advanced and more aggressive BCs compared to their older counterparts. Routine breast self-examination is recommended for all Ghanaian women to enable early detection and the appropriate management. Genetics studies are needed to further evaluate the biology of BC in younger Ghanaian women. 
